Advances in the anemia of chronic disease

International Journal of Hematology

Volumn 70, Issue 1, 1999, Pages 7-12

  Means Jr , Robert T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anemia; Cytokines; Erythropoiesis; Ferrokinetics; Interferon ; Interferon ; Interleukin 1; Tumor necrosis factor

Indexed keywords

CYTOKINE; ERYTHROPOIETIN;

ANEMIA; CELL SURVIVAL; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNDROME;

ANEMIA; CELL SURVIVAL; CHRONIC DISEASE; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTES; ERYTHROPOIETIN; HUMANS; INFLAMMATION; SYNDROME;

EID: 0033162263     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lee GR. The anemia of chronic disease. Semin Hematol 1983;20:61-80.
2. Cash JM, Sears DA. The spectrum of diseases associated with the anemia of chronic disease: a study of 90 cases. Am J Med 1990;87:638-44.
3. Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 1990;14:209-23.
4. Miller RK, Altz-Smith M. Usefulness of serum ferritin in detecting iron deficiency in rheumatoid arthritis (RA). Arthritis Rheum 1982;25:S114.
5. Means RT, Allen J, Sears DA, Schuster SJ. Serum soluble transferrin receptor and the prediction of marrow aspirate results in a heterogeneous group of patients. Clin Lab Haemat 1999;22, in press.
6. North M, Dallalio G, Donath AS, Melink R, Means RT. Serum transferrin receptor levels in patients undergoing evaluation of iron stores: correlation with other parameters, and observed versus predicted results. Clin Lab Haemat 1997;19:93-7.
7. Abe Y, Muta K, Nishimura J, Nawata H. Regulation of transferrin receptors by iron in human erythroblasts. Am J Hematol 1992;40:270-5.
8. Feelders RA, Vreugdenhil G, van Dijk JP, Swaak AJG, van Eijk HG. Decreased affinity and number of transferrin receptors on erythroblasts in the anemia of rheumatoid arthritis. Am J Hematol 1993;43:200-4.
9. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75:102-7.
10. Ferguson BJ, Skikine BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992;19:385-90.
11. Jefferey MR. Some observations on anemia in rheumatoid arthritis. Blood 1953;8:502-18.
12. Vilcek J, Gray PW, Rinderknecht E, Sevastopoulos CG. Interferon (gamma): a lymphokine for all seasons. Lymphokines 1985;11:1-32.
13. Hooks JJ, Moutsopopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AC. Immune Interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979;301:5-8.
14. Maury CPJ, Andersson LC, Teppo A-M, Partanen S, Javonen E. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 (beta) concentration in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukemia (HEL) cells in vitro. Ann Rheum Dis 1988;47:972-8.
15. Balkwill F, Burke F, Talbot D, et al. Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 1987;2:1229-32.
16. Teppo A-M, Maury CPJ. Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987;33:2024-7.
17. Mauritz NJ, Holmdahl R, Jonsson R, Van der Meide PH, Scheynius A, Klarskug L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum 1988;31:1297-303.
18. Cartwright GE. The anemia of chronic disease. Semin Hematol 1966;3:351-75.
19. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-47.
20. Salvarini C, Casali B, Salvo D, et al. The role of interleukin 1, erythropoietin, and red cell bound immunoglobulins in the anaemia of rheumatoid arthritis. Clin Exp Rheumatol 1991;9:241-6.
21. Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989;3:1637-43.
22. Rice L, Alfrey CP, Driscoll T, Whitley CE, Hachey DL, Suki W. Neoctyoloysis contributes to the anemia of renal disease. Am J Kidney Dis 1999;33:59-62.
23. Erslev AJ, Caro J, Miller O, Silver R. Plasma erythropietin in health and disease. Ann Lab Clin Sci 1980;10:250-7.
24. Baer AN, Dessypris EN, Goldwasser E, Krantz SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987;66:559-64.
25. Miller CB, Jones RJ, Zahurak ML, et al. Impaired erythropoietin response to anemia after bone marrow transplantation. Blood 1992;80:2677-82.
26. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79:1987-94.
27. Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1991;50:301-8.
28. Tracey KJ, Wei H, Nanogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988;167:1211-27.
29. Roodman GD, Bird A, Hutzler D, Montgomery W. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, HEL cells. Exp Hematol 1987;15:928-35.